Patents by Inventor Garry Pairaudeau

Garry Pairaudeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Patent number: 8158820
    Abstract: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
    Type: Grant
    Filed: April 6, 2004
    Date of Patent: April 17, 2012
    Assignee: AstraZeneca AB
    Inventors: Roger Bonnert, Stephen Brough, Andrew Davies, Timothy Luker, Thomas McInally, Ian Millichip, Garry Pairaudeau, Anil Patel, Rukhsana Rasul, Stephen Thom
  • Novel Compounds
    Publication number: 20110166117
    Abstract: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
    Type: Application
    Filed: December 30, 2010
    Publication date: July 7, 2011
    Inventors: Roger Bonnert, Stephen Brough, Andrew Davies, Timothy Luker, Thomas McInally, Ian Millichip, Garry Pairaudeau, Anil Patel, Rukhsana Rasul, Stephen Thom
  • Bezothiazol derivatives as Beta2 adrenoreceptor agonists
    Patent number: 7951954
    Abstract: The present invention relates to compounds according to formula (I), a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta adrenoreceptor agonists.
    Type: Grant
    Filed: March 12, 2007
    Date of Patent: May 31, 2011
    Assignee: AstraZeneca AB
    Inventors: Lilian Alcaraz, Andrew Lister, Garry Pairaudeau
  • Novel Benzothiazolone Derivatives
    Publication number: 20100210688
    Abstract: The present invention provides compounds of formula (I) wherein e, R1, R2, R3, R4, R5, R4, R5, R6, R7, R7a, R7b, A, D, m and n are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: April 27, 2010
    Publication date: August 19, 2010
    Inventors: Roger Bonnert, Alice Flaherty, Garry Pairaudeau, Michael Stocks
  • Benzothiazolone derivatives
    Patent number: 7709511
    Abstract: The present invention provides compounds of formula (I) wherein e, R1, R2, R3, R4, R5, R4, R5, R6, R7, R7a, R7b, A, D, m and n are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: May 4, 2010
    Assignee: AstraZeneca AB
    Inventors: Roger Bonnert, Alice Flaherty, Garry Pairaudeau, Michael Stocks
  • Cathepsin cysteine protease inhibitors and their use
    Patent number: 7605159
    Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: October 20, 2009
    Assignee: AstraZeneca AB
    Inventors: Judith McInally, Garry Pairaudeau, Anil Patel, Stephen Thom
  • Alkyl Esters Of Cyclic Amino Alcohols With Muscarinic M3 Receptor Antagonist Activity, Useful For Treating E.G. Chronic Bronchial Obstruction, Asthma And Overactive Bladder
    Publication number: 20090233965
    Abstract: The invention provides compounds of formula (I), wherein R1, R2, R3, R4, R5 and X are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them, a process for preparing pharmaceutical compositions and their use in therapy (I).
    Type: Application
    Filed: April 23, 2007
    Publication date: September 17, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Andrew Bailey, Antonio Mete, Garry Pairaudeau, Michael Stocks, Mark Wenlock
  • 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonists
    Publication number: 20090221653
    Abstract: The present invention provides compounds of formula (I) wherein the variables are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: August 28, 2006
    Publication date: September 3, 2009
    Applicant: AstraZeneca AB
    Inventors: Andrew Bailey, Roger Bonnert, Stephen Connolly, Anthony Ingall, Garry Pairaudeau, Michael Stocks
  • 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonists
    Publication number: 20090203753
    Abstract: The present invention provides compounds of formula (I) wherein e, R1, R2, R3, R4, R5, R4?, R5?, R6, R7, A, D, m and n are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: August 28, 2006
    Publication date: August 13, 2009
    Applicant: AstraZeneca AB
    Inventors: Andrew Bailey, Roger Bonnert, Alice Flaherty, Garry Pairaudeau, Michael Stocks
  • Bezothiazol Derivatives as Beta2 Adrenoreceptor Agonists
    Publication number: 20090062259
    Abstract: The present invention relates to compounds according to formula (I), a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta adrenoreceptor agonists.
    Type: Application
    Filed: March 12, 2007
    Publication date: March 5, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Lilian Alcaraz, Andrew Lister, Garry Pairaudeau
  • PHENETHANOLAMINE DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS
    Publication number: 20090029958
    Abstract: The present invention relates to compounds according to formula (I), a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta2 adrenoreceptor agonists.
    Type: Application
    Filed: March 6, 2007
    Publication date: January 29, 2009
    Inventors: Lilian Alcaraz, Andrew Bailey, Rhona Cox, Premji Meghani, Garry Pairaudeau, Michael Stocks
  • Novel Benzothiazolone Derivatives
    Publication number: 20080300275
    Abstract: The present invention provides compounds of formula (I) wherein e, R1, R2, R3, R4, R5, R4, R5, R6, R7, R7a, R7b, A, D, m and n are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: August 3, 2006
    Publication date: December 4, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Roger Bonnert, Alice Flaherty, Garry Pairaudeau, Michael Stocks
  • Purine-or pyrrolol[2,3-d]pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity
    Patent number: 7439240
    Abstract: The present invention therefore provides a compound of formula (I) and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.
    Type: Grant
    Filed: June 23, 2003
    Date of Patent: October 21, 2008
    Assignee: AstraZeneca AB
    Inventors: Andrew Bailey, Garry Pairaudeau, Anil Patel, Stephen Thom
  • Novel Compounds
    Publication number: 20080234274
    Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.
    Type: Application
    Filed: June 3, 2008
    Publication date: September 25, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Andrew Bailey, Garry Pairaudeau, Anil Patel, Stephen Thom
  • Novel Compounds
    Publication number: 20080125426
    Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.
    Type: Application
    Filed: February 1, 2008
    Publication date: May 29, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Andrew Bailey, Garry Pairaudeau, Anil Patel, Stephen Thom
  • Novel Compounds
    Publication number: 20080119469
    Abstract: The present invention relates to compounds and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S. In addition this invention also discloses processes for the preparation of such inhibitors.
    Type: Application
    Filed: February 1, 2008
    Publication date: May 22, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Andrew Bailey, Garry Pairaudeau, Anil Patel, Stephen Thom
  • Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
    Publication number: 20070249686
    Abstract: The invention relates to substituted acids as useful pharmaceutical compounds for treating respiratory disorders as asthma, pharmaceutical compositions containing them, and processes for their preparation.
    Type: Application
    Filed: October 3, 2005
    Publication date: October 25, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Roger Bonnert, Timothy Luker, Garry Pairaudeau, Stephen Thom
  • Novel compounds
    Publication number: 20060264435
    Abstract: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
    Type: Application
    Filed: April 6, 2004
    Publication date: November 23, 2006
    Inventors: Roger Bonnert, Stephen Brough, Andrew Davies, Timothy Luker, Thomas McInally, Ian Millichip, Garry Pairaudeau, Anil Patel, Rukshana Rasul, Stephen Thom
  • Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
    Patent number: 7125881
    Abstract: The present invention therefore provides use of a compound of formula (I) and compositions for treating diseases associated with cysteine protease activity. The compounds are reversible inhibitors of cysteine proteases S, K, F, L and B. Of particular interest are diseases associated with Cathepsin S.
    Type: Grant
    Filed: June 23, 2003
    Date of Patent: October 24, 2006
    Assignee: AstraZeneca AB
    Inventors: Andrew Bailey, Garry Pairaudeau, Anil Patel, Stephen Thom
  • Novel compounds
    Publication number: 20060211765
    Abstract: The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
    Type: Application
    Filed: April 6, 2004
    Publication date: September 21, 2006
    Applicant: ASTRAZENECA AB
    Inventors: Garry Pairaudeau, Rukhsana Rasul, Stephen Thom